Pregled bibliografske jedinice broj: 510589
Pharmacokinetic, pharmacodynamic, and safety profiles of PEGylated interferon beta-1a in healthy volunteers: Results from two phase 1 studies
Pharmacokinetic, pharmacodynamic, and safety profiles of PEGylated interferon beta-1a in healthy volunteers: Results from two phase 1 studies // Cytokine 48:21
Lisabon, Portugal, 2009. (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 510589 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Pharmacokinetic, pharmacodynamic, and safety profiles of PEGylated interferon beta-1a in healthy volunteers: Results from two phase 1 studies
Autori
Davar, Gudarz ; Richman, S. ; Glick, G. ; Subramanyam, Meena ; Hu, Xia ; Lerner, Michaela ; Miller, Larisa ; Nestorov, Ivan ; Liu, S. ; Zhu, Y. ; Baker, Darren ; Panzara, Michael
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Cytokine 48:21
/ - , 2009
Skup
17th Annual Meeting of the International Cytokine Society (5th Joint Meeting with ISICR and SLB)
Mjesto i datum
Lisabon, Portugal, 17.10.2009. - 21.10.2009
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Pharmacokinetics; pharmacodynamics; safety; clinical study; PEGylated interferon beta-1a
Sažetak
Pharmacokinetics, pharmacodynamics and safety profiles of PEGylated interferon beta-1a were studied in two phase I clinical studies in healthy volunteers. Data supports further clinical development of PEGylated interferon beta-1a in phase III clinical study in relapsing multiple sclerosis.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb
